• Je něco špatně v tomto záznamu ?

European consensus conference on unruptured brain AVMs treatment (Supported by EANS, ESMINT, EGKS, and SINCH)

M. Cenzato, E. Boccardi, E. Beghi, P. Vajkoczy, I. Szikora, E. Motti, L. Regli, A. Raabe, S. Eliava, A. Gruber, TR. Meling, M. Niemela, A. Pasqualin, A. Golanov, B. Karlsson, A. Kemeny, R. Liscak, B. Lippitz, M. Radatz, A. La Camera, R. Chapot,...

. 2017 ; 159 (6) : 1059-1064. [pub] 20170407

Jazyk angličtina Země Rakousko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18010692

In December of 2016, a Consensus Conference on unruptured AVM treatment, involving 24 members of the three European societies dealing with the treatment of cerebral AVMs (EANS, ESMINT, and EGKS) was held in Milan, Italy. The panel made the following statements and general recommendations: (1) Brain arteriovenous malformation (AVM) is a complex disease associated with potentially severe natural history; (2) The results of a randomized trial (ARUBA) cannot be applied equally for all unruptured brain arteriovenous malformation (uBAVM) and for all treatment modalities; (3) Considering the multiple treatment modalities available, patients with uBAVMs should be evaluated by an interdisciplinary neurovascular team consisting of neurosurgeons, neurointerventionalists, radiosurgeons, and neurologists experienced in the diagnosis and treatment of brain AVM; (4) Balancing the risk of hemorrhage and the associated restrictions of everyday activities related to untreated unruptured AVMs against the risk of treatment, there are sufficient indications to treat unruptured AVMs grade 1 and 2 (Spetzler-Martin); (5) There may be indications for treating patients with higher grades, based on a case-to-case consensus decision of the experienced team; (6) If treatment is indicated, the primary strategy should be defined by the multidisciplinary team prior to the beginning of the treatment and should aim at complete eradication of the uBAVM; (7) After having considered the pros and cons of a randomized trial vs. a registry, the panel proposed a prospective European Multidisciplinary Registry.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18010692
003      
CZ-PrNML
005      
20180413143225.0
007      
ta
008      
180404s2017 au f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00701-017-3154-8 $2 doi
035    __
$a (PubMed)28389875
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a au
100    1_
$a Cenzato, Marco $u Neurosurgery, Grande Ospedale Metropolitano Niguarda, Milan, Italy. marco.cenzato@ospedaleniguarda.it.
245    10
$a European consensus conference on unruptured brain AVMs treatment (Supported by EANS, ESMINT, EGKS, and SINCH) / $c M. Cenzato, E. Boccardi, E. Beghi, P. Vajkoczy, I. Szikora, E. Motti, L. Regli, A. Raabe, S. Eliava, A. Gruber, TR. Meling, M. Niemela, A. Pasqualin, A. Golanov, B. Karlsson, A. Kemeny, R. Liscak, B. Lippitz, M. Radatz, A. La Camera, R. Chapot, C. Islak, L. Spelle, A. Debernardi, E. Agostoni, M. Revay, MK. Morgan,
520    9_
$a In December of 2016, a Consensus Conference on unruptured AVM treatment, involving 24 members of the three European societies dealing with the treatment of cerebral AVMs (EANS, ESMINT, and EGKS) was held in Milan, Italy. The panel made the following statements and general recommendations: (1) Brain arteriovenous malformation (AVM) is a complex disease associated with potentially severe natural history; (2) The results of a randomized trial (ARUBA) cannot be applied equally for all unruptured brain arteriovenous malformation (uBAVM) and for all treatment modalities; (3) Considering the multiple treatment modalities available, patients with uBAVMs should be evaluated by an interdisciplinary neurovascular team consisting of neurosurgeons, neurointerventionalists, radiosurgeons, and neurologists experienced in the diagnosis and treatment of brain AVM; (4) Balancing the risk of hemorrhage and the associated restrictions of everyday activities related to untreated unruptured AVMs against the risk of treatment, there are sufficient indications to treat unruptured AVMs grade 1 and 2 (Spetzler-Martin); (5) There may be indications for treating patients with higher grades, based on a case-to-case consensus decision of the experienced team; (6) If treatment is indicated, the primary strategy should be defined by the multidisciplinary team prior to the beginning of the treatment and should aim at complete eradication of the uBAVM; (7) After having considered the pros and cons of a randomized trial vs. a registry, the panel proposed a prospective European Multidisciplinary Registry.
650    _2
$a kongresy jako téma $7 D003226
650    12
$a konsensus $7 D032921
650    _2
$a Evropská unie $7 D005062
650    _2
$a lidé $7 D006801
650    _2
$a intrakraniální arteriovenózní malformace $x chirurgie $7 D002538
650    _2
$a neurochirurgické výkony $x normy $7 D019635
650    12
$a směrnice pro lékařskou praxi jako téma $7 D017410
650    _2
$a randomizované kontrolované studie jako téma $x normy $7 D016032
650    _2
$a registrace $x normy $7 D012042
655    _2
$a časopisecké články $7 D016428
700    1_
$a Boccardi, Edoardo $u Neuroradiology, Metropolitan Hospital Niguarda, Milan, Italy.
700    1_
$a Beghi, Ettore $u Neurology, Methodologist, IRCCS Istituto Mario Negri, Milan, Italy.
700    1_
$a Vajkoczy, Peter $u Neurosurgery, Charitè Universitatetsmedizin, Berlin, Germany.
700    1_
$a Szikora, Istvan $u Neuroradiology, National Institute of NeuroScience, Budapest, Hungary.
700    1_
$a Motti, Enrico $u Radiosurgery, Ospedale Villa Maria di Cotignola, Ravenna, Italy.
700    1_
$a Regli, Luca $u Neurosurgery, UniversitaetsSpital, Zurich, Switzerland.
700    1_
$a Raabe, Andreas $u Neurosurgery, Inselspital, Bern, Switzerland.
700    1_
$a Eliava, Shalva $u Neurosurgery, Burdenko Hospital, Moscow, Russia.
700    1_
$a Gruber, Andreas $u Neurosurgery and Neuroradiology, University Hospital, Lintz, Austria.
700    1_
$a Meling, Torstein R $u Neurosurgery, National Hospital, Oslo, Norway.
700    1_
$a Niemela, Mika $u Neurosurgery, University Hospital, Helsinki, Finland.
700    1_
$a Pasqualin, Alberto $u Neurosurgery, Ospedale Maggiore Civile, Verona, Italy.
700    1_
$a Golanov, Andrey $u Radiosurgery, Burdenko Hospital, Moscow, Russia.
700    1_
$a Karlsson, Bengt $u Radiosurgery, Singapore Gamma Knife Center, Singapore, Singapore.
700    1_
$a Kemeny, Andras $u Radiosurgery, Thornbury Radiosurgery Centre, Sheffield, UK.
700    1_
$a Liscak, Roman $u Radiosurgery, Na Homolce Hospital, Prague, Czech Republic.
700    1_
$a Lippitz, Bodo $u Radiosurgery, Bupa Cromwell Hospital, London, UK.
700    1_
$a Radatz, Matthias $u Radiosurgery, Royal Hallamshire Hospital, Sheffield, UK.
700    1_
$a La Camera, Alessandro $u Radiosurgery, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
700    1_
$a Chapot, René $u Neuroradiology, Krupp Hospital, Hessen, Germany.
700    1_
$a Islak, Civan $u Neuroradiology, Cerrahpaşa Medical Faculty, İstanbul University, Istanbul, Turkey.
700    1_
$a Spelle, Laurent $u Neuroradiology, Bicetre University Hospital, Paris, France.
700    1_
$a Debernardi, Alberto $u Neurosurgery, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
700    1_
$a Agostoni, Elio $u Neurology, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
700    1_
$a Revay, Martina $u Neurosurgery, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
700    1_
$a Morgan, Michael K $u Neurosurgery, Macquaire University, Sydney, Australia.
773    0_
$w MED00009022 $t Acta neurochirurgica $x 0942-0940 $g Roč. 159, č. 6 (2017), s. 1059-1064
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28389875 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180404 $b ABA008
991    __
$a 20180413143318 $b ABA008
999    __
$a ok $b bmc $g 1288177 $s 1007504
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 159 $c 6 $d 1059-1064 $e 20170407 $i 0942-0940 $m Acta neurochirurgica $n Acta Neurochir $x MED00009022
LZP    __
$a Pubmed-20180404
Zpět

Najít záznam

Citační ukazatele

    Možnosti archivace